• SENSEX 76,391.39
    -363.66 (--0.47%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • HDFC Bank
    743.25 726.75(%)
  • CIE Automotive
    411.35 382.20(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Bluestone Jewel
    732.05 400.40(%)
  • Bharti Airtel
    1,925.60 1,745.00(%)
  • Reliance Industries
    1,268.00 1,253.65(%)
  • Bajaj Finance
    1,037.00 788.40(%)
  • Bajaj Finserv
    1,900.15 2,194.65(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Maruti Suzuki
    13,371.65 12,202.10(%)
  • Gandhar Oil Ref.
    283.85 245.00(%)
  • Route Mobile
    649.90 949.80(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,372.70 767.00(%)
  • Infosys
    1,032.30 984.00(%)
  • IndusInd Bank
    999.00 710.85(%)
  • SBI
    1,006.50 786.55(%)
  • Axis Bank
    1,219.05 1,041.30(%)
  • CG Power & Ind
    881.00 525.50(%)
  • SBI Funds Mgt.
    575.35 582.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Organics Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92885.0
  • ISIN : INE0PE401018
25.00 1 (4.17%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    25.00

  • Today’s High

    25.20

  • Open

    25.20

  • Perv Close

    24.00

  • 52W Low

    19.10

  • 52W High

    45.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    30.41

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.68

  • Debt-Equity Ratio

    4.17

  • AGM Date

    22-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    30.41

  • RONW (%)

    13.11

  • ROCE (%)

    14.33

Score Board

  • Equity (₹ in Cr.)

    12.17

  • BV (₹)

    23.70

  • Sales( ₹ in Cr.)

    21.65

  • NP (in Cr.)

    -3.05

  • NP Var(%)

    -193.0

  • Div%

    0.0

  • CPS (₹)

    -1.80

  • EPS (₹)

    -2.50

  • Traded Value (₹ in Lakhs)

    30.41

  • 52 Week High

    45.00

  • 52 Week Low

    19.10

  • Price BSE

    0.0

  • Price NSE

    25.00

  • Market Capital( in Cr.)

    30.41

  • P/C Ratio

    -14.10

  • P/E Ratio

    -10.00

  • Price Vs.BV

    -2.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 37.09 25.27 22.15 20.98 25.05 31.49
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 37.09 25.27 22.15 20.98 25.05 31.49
Other Income 0.10 0.02 0.82 0.21 0.01 0.09
Stock Adjustments 0.81 1.47 0.60 0.71 -0.55 0.19
Total Income 38.00 26.76 23.57 21.90 24.51 31.77
EXPENDITURE :            
Raw Materials 12.78 10.64 10.56 14.12 15.31 15.91
Power and Fuel Cost 0.91 0.99 0.82 0.72 0.91 1.20
Employee Cost 3.23 2.99 2.87 2.49 2.33 2.58
Other Manufacturing Expenses 11.96 5.69 5.06 1.56 2.05 8.84
Selling and Administration Expenses 2.31 1.48 1.47 1.47 1.80 1.59
Miscellaneous Expenses 1.13 -0.84 0.10 0.14 0.47 0.20
Employee Benefit Expenses 3.23 2.99 2.87 2.49 2.33 2.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 32.32 20.96 20.88 20.49 22.86 30.33
Operating Profit 5.66 5.81 2.68 1.41 1.65 1.44
Interest 0.54 0.65 0.61 0.47 0.48 0.46
Gross Profit 5.12 5.16 2.07 0.94 1.17 0.98
Depreciation 0.74 0.72 0.71 0.68 0.68 0.77
Profit Before Tax 4.38 4.44 1.36 0.26 0.49 0.21
Current Tax 1.14 0.96 0.34 0.10 0.12 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 0.85 0.05 0.06 0.08 0.06
Reported Net Profit 3.27 2.62 0.97 0.09 0.30 0.10
Extraordinary Items 0.00 0.62 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.27 2.00 0.97 0.09 0.30 0.10
Adjustment below Net Profit -0.10 0.14 0.00 0.00 0.06 0.01
P & L Balance brought forward 4.55 1.78 1.10 0.55 0.19 0.09
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 7.72 4.55 2.07 0.64 0.55 0.19
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.80 3.05 1.62 0.15 0.50 0.17
Earnings Per Share(Adj)-Unit Curr 2.80 - - - - -
Book Value 24.76 17.74 14.97 12.60 12.45 11.85
Book Value(Adj)-Unit Curr 24.76 - - - - -

Shareholding Pattern

  • Promoter Group

    54.89%

  • Public Share Holding

    45.11%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,168,095 54.89 8,168,095 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,168,095 54.89 8,168,095 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,000 0.05 8,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,000 0.05 8,000 1
2] Non Institution
Bodies Corporate 284,000 1.91 284,000 14
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,726,000 18.32 2,726,000 19
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 98,000 0.66 98,000 14
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,658,000 11.14 1,658,000 22
Individuals holding nominal share capital up to Rs. 1 lakh 1,938,100 13.02 1,938,100 433
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,704,100 45.05 6,704,100 502
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 14,880,195 100.00 14,880,195 508

Company Background

Medicamen Organics LtdPharmaceuticals - Indian - Formulations

  • Medicamen Organics Ltd
  • BSE Code : 92885.0
  • ISIN : INE0PE401018

  • Incorporation Year

    1995

  • Registered Office

    10 Community Centre No 2
    Ashok Vihar Phase II, New Delhi,
    Delhi-110052

  • Telephone

    +91 98182 22845

  • FAX

  • Chairman

    B K Gupta

  • Managing Director

    B K Gupta

  • Company Secretary

    Varsha Bansal

  • Auditor

    N C Raj & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Medicamen Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen Organ. 25.00 37.18 37.09 -10.00 14.04
Abbott India 28,898.60 7,217.19 6,929.05 39.57 43.78
Astrazeneca Phar 8,033.05 2,304.07 2,275.58 107.09 27.86
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 474.15 450.25 19.27 18.77
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77